Explore more publications!

Elections Post Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Elections Post Observer.

Press releases published on December 23, 2025

Annual Mercedes-Benz of Wilsonville Santa Paws
CITY OF CARSON RECOGNIZED FOR LEADERSHIP IN  ENERGY EFFICIENCY AND SUSTAINABILITY
India Urged to Ensure Sri Lanka Aid Is Not Used to Impose Cultural Symbols or Rewrite Tamil History
Barbados Real Estate 2025 End-of-Year Review
Southern Transitional Council moves to consolidate security and administration in Yemen’s South amid government absence
DCHFA Closes the Year by Financing 199 Affordable Homes Across Wards 7 and 8
Weekly share repurchase program transaction details
Transaction in Own Shares
Northfield and Juno Welcome Historic Federal-Provincial Agreement to Accelerate Ring of Fire Development
ABC Calls on Congress to Act Now to Modernize Blood Center Regulations
Press Release: Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia
Communiqué de presse : Wayrilz de Sanofi approuvé dans l’UE comme premier inhibiteur de la BTK pour le traitement de la thrombocytopénie immunitaire (TPI)
Upexi Files Shelf Registration Statement on Form S-3 with the U.S. SEC
SunPower Q3’25 10Q Report Filed
Red Cat Supports Administration’s Accelerated Enforcement of NDAA Section 1709, Highlights Need for U.S. Drone Ecosystem Investment
Vantiva Board of Directors Elects Katleen Vandeweyer as Chairwoman of the Board
Le Conseil d’administration de Vantiva élit Katleen Vandeweyer Présidente du Conseil
Press Release: Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma
Communiqué de presse : Le Dupixent de Sanofi et Regeneron approuvé au Japon pour les enfants de 6 à 11 ans atteints d’asthme bronchique

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions